These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2436774)

  • 1. Estrogen staining in breast carcinoma by PAP methods compared to CEA and ferritin staining.
    Osamu K; Takashi M; Yohichi T; Yasuo U; Tetsuro Y; Yoshiro F; Toshio T
    Cancer Detect Prev; 1987; 10(1-2):113-20. PubMed ID: 2436774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic contributions of Helix pomatia and carcinoembryonic antigen staining using histochemical techniques in breast carcinomas.
    Fukutomi T; Itabashi M; Tsugane S; Yamamoto H; Nanasawa T; Hirota T
    Jpn J Clin Oncol; 1989 Jun; 19(2):127-34. PubMed ID: 2733166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of estrogen, progesterone, CEA and ferritin in breast cancer and their clinical value for the prediction of early postoperative recurrence.
    Majima T; Kojima O; Uehara Y; Tokuda H; Kano M; Takahashi T
    Jpn J Surg; 1987 Jul; 17(4):243-7. PubMed ID: 3682432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA positivity in tissue and sera of patients with benign breast lesions.
    Wittekind C; Von Kleist S; Sandritter W
    Oncodev Biol Med; 1981; 2(6):381-90. PubMed ID: 7346797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.
    Charpin C; Martin PM; Jacquemier J; Lavaut MN; Pourreau-Schneider N; Toga M
    Cancer Res; 1986 Aug; 46(8 Suppl):4271s-4277s. PubMed ID: 3524808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistological studies for demonstration of carcinoembryonic antigen in benign breast lesions].
    Wittekind C; von Kleist S; Sandritter W
    Onkologie; 1982 Aug; 5 Suppl():25-7. PubMed ID: 6752789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
    Dalifard I; Daver A; Cellier P; Larra F
    Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
    Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
    Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Male breast cancer: clinical, pathologic and immunohistochemical study].
    Xu RN
    Zhonghua Wai Ke Za Zhi; 1989 Jan; 27(1):28-30, 61. PubMed ID: 2776523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
    Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
    Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CEA and breast neoplasms: application of a personal method for determination of CEA in the clinical study of 242 patients (author's transl)].
    Dell'anna B; Percudani M; Salvadori C
    Bull Cancer; 1979; 66(3):259-67. PubMed ID: 486732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
    Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
    Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructural study of carcinoembryonic antigen (CEA) using the peroxidase-antiperoxidase (PAP) complex technic in patients with breast cancer].
    Grzanka A; Domaniewski J
    Patol Pol; 1989; 40(3):325-33. PubMed ID: 2701332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor immunocytochemical assay (ERICA) and laminin detection in 130 breast carcinomas and computerized (Samba 200) multiparametric quantitative analysis on tissue sections.
    Charpin C; Martin PM; Lissitzky JC; Jacquemier J; Kopp F; Pourreau-Schneider N; Lavaut MN; Toga M
    Bull Cancer; 1986; 73(6):651-64. PubMed ID: 3567371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
    Murthy L; Kapila K; Verma K
    Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
    McCarty KS; Szabo E; Flowers JL; Cox EB; Leight GS; Miller L; Konrath J; Soper JT; Budwit DA; Creasman WT
    Cancer Res; 1986 Aug; 46(8 Suppl):4244s-4248s. PubMed ID: 3524805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies].
    Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K
    Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of elevated carcinoembryonic antigen on absorbent disks applied to nipple area of breast carcinoma patients.
    Imayama S; Mori M; Ueo H; Nanbara S; Adachi Y; Mimori K; Shimozono Y; Hori Y; Sugimachi K
    Cancer; 1996 Sep; 78(6):1229-34. PubMed ID: 8826944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.